Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apellis, Aquestive, Ascendis, Bavarian, Bioarctic, Eisai, Genmab, Grin, Oncopeptides, Pfizer, Pharvaris, Santen, Sydnexis.